Get started
Author

Pamela Navarro‐Gonzales

Observed names: Navarro-Gonzales, Pamela, Pamela C. Navarro Gonzales, Pamela Navarro-Gonzales
ORCID: 0009-0007-1204-8246
Observed ORCID: 0009-0007-1204-8246
OpenAlex ID: A5074908684
Effect of Moderate Hepatic Impairment on the Pharmacokinetics of Vadadustat, an Oral Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitor
2021 · Ajit Chavan, Leontia Burke, et al. · Clinical Pharmacology in Drug Development · 19
Pharmacokinetics, Pharmacodynamics, and Safety of Vadadustat in Healthy Volunteers and Patients with Chronic Kidney Disease
2024 · Pamela Navarro‐Gonzales, Tomas Ganz, et al. · Clinical Pharmacology & Therapeutics · 12
A randomized trial to evaluate the pharmacokinetics, pharmacodynamics, and safety of vadadustat in patients with anemia associated with chronic kidney disease receiving hemodialysis
2025 · Pamela Navarro-Gonzales, Ajit Chavan, et al. · BMC Nephrology · 1
PDF
Framework to Assess the Benefits and Risks of Treatments and Dosing Regimens for Anemia of CKD
2024 · Kevin Dykstra, Todd Eric Minga, et al. · Journal of the American Society of Nephrology
#2898 Exposure response model describing hematologic changes with chronic treatment of CKD anemia with vadadustat
2024 · Kevin Dykstra, Pamela Navarro-Gonzales · Nephrology Dialysis Transplantation
PDF
Works count: 7
Citation count: 32
H-index: 2
I10-index: 2
Year
Topic
Type